Exchange: NASDAQ·Updated 04:00 AM EDT

OLMA News

News
all
press releases
Futures Slide As Tech Tumbles On Fears Of AI Slowdown, Oil Jumps
Futures Slide As Tech Tumbles On Fears Of AI Slowdown, Oil Jumps US futures are sliding, dragged by fears of a possible AI development slowdown as well as higher oil prices (Brent > 108), though bond yields are not reacting yet (10Y yield still under 5%). As of 8:00am ET, S&P futures...
Zero Hedge
More News
Olema Appoints Jason O'Byrne As CFO
(RTTNews) - Olema Pharmaceuticals Inc. (OLMA), a clinical-stage biopharmaceutical company, on Thursday appointed Jason O'Byrne as Chief Financial Officer...
Nasdaq News: Markets
Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027
Olema Pharmaceuticals shares fall after completing OPERA-01 Phase 3 enrollment, with top-line data now expected in Q1 2027.read more...
Benzinga
Lilly’s Phase 3 Breakthrough Ignites Race for the Next Cancer Stock Breakout
Eli Lilly (NYSE:LLY) has once again captured the attention of the oncology community after reporting remarkably strong Phase 3 results for Retevmo (selpercatinib) in early-stage RET fusion-positive non-small cell lung cancer. $LLY, $NTHI, $COGT, $OLMA, $BMY, $PFE
24-7 Market News
Olema Oncology Sees Early Hope As Cancer Drug Shows Tumor Shrinkage In Phase 1 Study
Early ASCO data for OP-3136 pointed to encouraging anti-cancer activity with a clean safety profile, adding momentum to OLMA’s pipeline story.
Stocktwits
Olema Pharmaceuticals (OLMA) Expected to Announce Quarterly Earnings on Tuesday
Olema Pharmaceuticals (NASDAQ:OLMA) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-olema-pharmaceuticals-inc-stock...
MarketBeat
Jennison Associates LLC Takes Position in Olema Pharmaceuticals, Inc. $OLMA
Jennison Associates LLC purchased a new stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 963,997 shares of the company's stock, valued at approximatel...
MarketBeat
Pictet Asset Management Holding SA Trims Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA
Pictet Asset Management Holding SA lessened its holdings in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 69.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 502,568...
MarketBeat
Wall Street Zen Upgrades Olema Pharmaceuticals (NASDAQ:OLMA) to "Sell"
Wall Street Zen raised Olema Pharmaceuticals from a "strong sell" rating to a "sell" rating in a research report on Monday...
MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the fourteen brokerages that are covering the company, Marketbeat...
MarketBeat

Advertisement|Remove ads.